Compound-Treated Stem Cell Composition for Spinal Cord Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacological treatments for spinal cord injury, such as methylprednisolone, have unclear therapeutic effects and side effects, while stem cell-based therapies lack a established method for effective nerve regeneration.
Innovation Solution
A composition using stem cells treated with a specific compound, such as N-(5-Chlorobenzo[d]oxazol-2-yl)-N-(4-ethylphenyl)-2-methoxyacetamide, is administered to differentiate into migrating neuroblasts, promoting nerve regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stem cells are transplanted to treat spinal cord injury, then nerve cell replacement and regeneration is promoted, but the therapeutic effect is insufficient without established differentiation control
Solution Approach 1:
The patent applies parameter changes by using a specific compound (Formula 1) to control the differentiation parameters of stem cells. The compound induces stem cells to differentiate into migrating neuroblasts through chemical parameter modification, providing reliable therapeutic effect without complex differentiation control methods.
Solution Approach 2:
The patent uses a specific compound as an intermediary substance between the stem cells and the desired differentiation outcome. This intermediary compound mediates the differentiation process, converting stem cells into migrating neuroblasts that can effectively treat spinal cord injury, simplifying the overall therapeutic approach.
2Reliability
If conventional stem cell transplantation is used, then nerve regeneration is promoted, but motor function recovery is limited
Solution Approach 1:
The patent applies preliminary action by pre-differentiating stem cells into migrating neuroblasts using the specific compound before transplantation. This preliminary differentiation step ensures that the transplanted cells are already in the appropriate state for promoting motor function recovery, increasing nerve regeneration efficiency rather than relying on post-transplantation differentiation.
3Speed
If pharmacological treatment is applied to primary injury, then immediate intervention is attempted, but treatment is ineffective due to rapid cell necrosis
Solution Approach 1:
The patent applies preliminary action by preparing stem cells with specific compound treatment before transplantation. This pre-differentiation prepares the cells in advance to immediately promote regeneration upon transplantation, bypassing the ineffective primary injury phase and directly addressing secondary injury mechanisms.
Data Source
AI summary
The present invention relates to a composition for treating a spinal cord injury and provides a composition for treating a spinal cord injury comprising, as an active ingredient, stem cells treated with a particular compound and then cultured.